Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

BRCA1/2 sequencing in Moroccan Breast cancer.

Domaine:

healthcare

Type de record:

dataset
Créateur:
Mel
Éditeur:
Mel
Éditeur:
Har
Hôte:avatar
Breast cancer is one of the most common malignancies and the leading cause of death among women worldwide. About 20% of breast cancers are hereditary. With the emergence of genetic testing, BRCA1/2 gene profiling was strongly recommended for women with a family history or early age onset of BC. The assessment of BRCA1/2 mutation carriers in familial breast cancer has been proved to be valuable not only in the perspective of prevention and early detection of related cancers but also it has implications in implementation of personalized medicine and chemoprevention of recurrence. This study is an attempt to fill some gaps and gain more information regarding the molecular germline profile of BRCA1/2 in the Moroccan population. The knowledge about the contribution of BRCA1 and BRCA2 mutations in Moroccan breast cancer will lead to better understanding of genetic risk factors of this disease in Morocco

Visit

doi.orgdataverse.harvard.edu

Tags

Medicine, Health and Life SciencesBRCA1_c.G5309T mutation

Licenses

info:eu-repo/semantics/openAccessCreative Commons Zero v1.0 Universalhttps://creativecommons.org/publicdomain/zero/1.0/legalcode

Similaires

98 BRCA1 and BRCA2 Mutation in Rwandan Unselected Breast Cancer PatientsContribution of BRCA1 and BRCA2 mutations to breast cancer in TunisiaBRCA1/2 variants and copy number alterations status in non familial triple negative breast cancer and high grade serous ovarian cancerScreening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patientsGermline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in TunisiaEvidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal

98 BRCA1 and BRCA2 Mutation in Rwandan Unselected Breast Cancer Patients

Abstract Introduction/Objective Back

Contribution of BRCA1 and BRCA2 mutations to breast cancer in Tunisia

e22191 Background: Hereditary breast cancer accounts for 3–8% of all breast cancers. It was recen

BRCA1/2 variants and copy number alterations status in non familial triple negative breast cancer and high grade serous ovarian cancer

Abstract Background While the role of BRCA1/2 genes in famili

Screening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patients

Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia

International audience Hereditary breast cancer accounts for 5-10% of all breast canc

Evidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal

Abstract BRCA1 and BRCA2 are the most incriminated genes in inherited breast/ovarian cancers. S